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It is becoming increasingly clear that the autonomic nervous
system and the immune system demonstrate cross-talk during
inflammation by means of sympathetic and parasympathetic path-
ways1,2. We investigated whether phagocytes are capable of de novo
production of catecholamines, suggesting an autocrine/paracrine
self-regulatory mechanism by catecholamines during inflam-
mation, as has been described for lymphocytes3. Here we show
that exposure of phagocytes to lipopolysaccharide led to a release
of catecholamines and an induction of catecholamine-generating
and degrading enzymes, indicating the presence of the complete
intracellular machinery for the generation, release and inactiva-
tion of catecholamines. To assess the importance of these findings
in vivo, we chose two models of acute lung injury. Blockade of
a2-adrenoreceptors or catecholamine-generating enzymes greatly
suppressed lung inflammation, whereas the opposite was the case
either for an a2-adrenoreceptor agonist or for inhibition of cate-
cholamine-degrading enzymes. We were able to exclude T cells or
sympathetic nerve endings as sources of the injury-modulating
catecholamines. Our studies identify phagocytes as a new source
of catecholamines, which enhance the inflammatory response.
Although tumor, rubor, dolor and calor (the Latin terms for swell-
ing, redness, pain and heat) are classical features of acute inflam-
mation, the proximal trigger of these responses is neuronal in
origin. Similarly, the systemic acute-phase response to infection
involves neurone-dependent responses (fever and activation of the
hormonal stress response), which are regulated mainly by the hypo-
thalamus2. Innate immunity and inflammation are the first lines of
defence4, with initial responses involving non-specific cellular and
humoral pathways, resulting in mediator release1. Immune and pro-
inflammatory mediators that are subsequently released rapidly activ-
ate neuronal responses that amplify local immune and inflammatory
responses designed to contain pathogens and trigger systemic neuro-
endocrine and regional neural responses that seek to return the sys-
tem to a homeostatic state2. One of the key pathways involved in the
neuroendocrine–immune modulating network is the autonomic
nervous system. Recently, vagal parasympathetic signalling has been
shown to have an important regulatory function in inflammation
through cholinergic receptors on phagocytic cells1,5,6. Functional
interplay of the adrenergic nervous system with the immune/inflam-
matory system may counterbalance effects of the parasympathetic
nervous system. The presence and synthesis of catecholamines in
lymphocytes were first described more than a decade ago3,7.
Catecholamines can thereby modulate the proliferation, differenti-
ation and apoptosis of lymphocytes and the production of cytokines
through adrenoreceptors expressed on T and B cells8–12. To invest-
igate whether macrophages and neutrophils (polymorphonuclear
cells; PMNs) might be able to generate and release catecholamines,
as has been suggested13,14, cells were incubated with bacterial lipopo-
lysaccharide (LPS) and levels of noradrenaline and adrenaline in cell
supernatants were determined. As shown in Fig. 1a–d, noradrenaline
and adrenaline levels increased significantly in cell supernatants
15 min after exposure of macrophages and PMNs to LPS, decreasing
at 1 h and 2 h, and then increasing by 4 h. Experiments were repeated
with human PMNs exposed to the potent complement anaphyla-
toxin C5a (10 nM), with virtually identical results (data not shown).
On the basis of these findings, we conducted experiments to evaluate
the presence of two key enzymes involved in catecholamine synthesis
in macrophages and PMNs after stimulation with LPS. Tyrosine
hydroxylase (TH) is known to be the rate-limiting step in catecho-
lamine synthesis, whereas dopamine b-hydroxylase (DBH) accounts
for the final step of noradrenaline synthesis, converting dopamine to
noradrenaline15. Macrophages or blood PMNs were incubated for
15 min and 4 h with 30 ng ml21 LPS. Thereafter, messenger RNA
expression for catecholamine-generating enzymes was analysed by
real-time polymerase chain reaction (PCR). Low baseline mRNA
levels for both key enzymes (TH and DBH) were detected in
unstimulated macrophages. At 4 h after cell exposure to LPS,
mRNAs for both enzymes were significantly upregulated (Fig. 1e,
f). PMNs expressed low constitutive levels of mRNA for TH and
DBH, but both were clearly upregulated 4 h after the addition of
LPS (Fig. 1g, h). The actions of catecholamines can be terminated
in three ways: by reuptake into nerve terminals, by diffusion into
extracellular fluids or by metabolic transformation. Two enzymes
are essential in the metabolic inactivation of catecholamines: monoa-
mine oxidase (MAO) and catechol O-methyltransferase (COMT).
Unstimulated macrophages contained mRNA for both COMT and
MAO-A (Fig. 2a, b). After exposure of cells to LPS, the quantity of
mRNA for COMT decreased whereas that for MAO-A increased. In
accordance with this, when proteins were analysed by western blot-
ting, exposure to LPS caused a decrease in macrophage COMT
(Fig. 2c), whereas the same intervention brought about higher levels
of MAO-A protein (Fig. 2d). Similar patterns were found in PMNs.
Incubation with LPS decreased the level of mRNA for COMT (Fig. 2e)
and increased that of mRNA for MAO-A (Fig. 2f). COMT protein
amounts decreased when PMNs were exposed to LPS (Fig. 2g); the
opposite was true for MAO-A (Fig. 2h). During COMT-mediated
O-methylation of catecholamines, S-adenosylmethionine (SAM)
serves as the methyl donor and is subsequently converted to
S-adenosyl-L-homocysteine (SAH) after donation of the methyl
group to the substrate. It has been known for many years that elevated
SAH levels can serve as a strong inhibitor of the COMT-mediated
O-methylation metabolism of catechols16,17. Increased phagocyte
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production of catecholamines might therefore lead to an increased
turnover of COMT, increasing levels of the powerful feedback inhi-
bitor SAH and ultimately causing the downregulation of cellular
mRNA and protein levels of COMT (Fig. 2). Collectively, these data
indicate that LPS-stimulated macrophages and PMNs express cate-
cholamine-generating and degrading enzymes and release noradre-
naline and adrenaline after exposure to LPS in vitro. Thus, phagocytes
possess the complete cellular machinery to generate catecholamines
de novo and to release and inactivate them.
To evaluate the relevance of these findings in vivo, we used two
different models of acute lung injury (induced by LPS and by IgG
immune complex) to study the effects of adrenoceptor blockade in
the setting of a single-organ injury. Adrenoceptors were blocked
in vivo by using the appropriate antagonists in the two different
models of lung inflammatory injury (Fig. 3a, c). The antagonists were
delivered intraperitoneally. Vascular leakage of albumin into lungs,
which correlates with lung injury, was measured after the deposition
of IgG immune complexes (IC) or LPS in the lung. a1-Adrenoceptors
were blocked by prazosin, whereas a2-adrenoceptors were blocked
with RX 821002. b1-Adrenoceptors were blocked by metoprolol, and
b2-adrenoceptor blockade was induced by ICI 118551. Only blockade
of the a2-adrenoceptors significantly reduced the intensity of the
albumin leak into lung in the two models of injury, whereas blockade
of other receptors neither intensified nor reduced the level of lung
injury (Fig. 3a, c). Blockade of the b2-adrenoceptors with different
doses of ICI 118551 (10–20 mg kg21) failed to alter injury intensity
significantly (data not shown). To clarify the significance of the
a2-adrenoceptors in our models of lung injury, an a2-adrenergic
agonist (UK 14304) was used to assess effects on lung injury. As
shown in Fig. 3b, d, the severity of lung damage increased twofold
and fourfold, respectively, when induction of IgG or LPS lung injury
was followed immediately by intraperitoneal administration of UK
14304, whereas the a2-adrenoceptor inhibitor RX 821002 substan-
tially suppressed lung injury in each of the two models. The effects of
these interventions were consistent with the morphological evalu-
ation of lungs (Fig. 3e–k). Although the levels of lung injury with LPS
and IC (positive controls) were comparable (Fig. 3f, i, respectively),
animals treated with UK 14304 showed clearly increased evidence of
injury as reflected in increased PMN numbers, fibrin and haem-
orrhage in the interstitial and alveolar compartments (Fig. 3g, j). In
sharp contrast, blockade of the a2-adrenoceptor by RX 821002
reduced the intensity of inflammation and injury (Fig. 4h, k) in com-































































































































































































































































































Figure 1 | Release of catecholamines from phagocytes and the presence of
catecholamine-producing enzymes in phagocytes. a–d, After isolation,
alveolar macrophages and blood PMNs were stimulated with 30 ng ml21 of
LPS in vitro. Cellular supernatant fluids were collected as a function of time
thereafter and then analysed by enzyme-linked immunosorbent assay for
noradrenaline (a, b) and adrenaline (c, d). HBSS served as negative control
(neg. ctrl). e–h, After stimulation with 30 ng ml21 of LPS, mRNA from alveolar
macrophages (e, f) and neutrophils (g, h) was isolated and subjected to real-
time PCR analysis for tyrosine hydroxylase and dopamine b-hydroxylase.
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Figure 2 | Expression of catecholamine-inactivating enzymes in
phagocytes. After isolation of macrophages and PMNs and stimulation in
vitro with 30 ng of LPS, mRNA and protein from alveolar macrophages
(a–d) and blood PMNs (e–h) were subjected to analysis by real-time PCR
(a, b, e, f) and western blotting (c, d, g, h) for the catecholamine-inactivating
enzymes COMT (a, c, e, g) or monoamine oxidase A (MAO-A)
(b, d, f, h). Western blots were repeated at least three separate times.
Representative blots are shown. Real-time PCR data are presented as means
6 s.e.m.; n $ 5 per bar. Neg. ctrl, negative control.
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a2-adrenoceptor in these models of lung injury. a2-Adrenoceptors
belong to the G-protein-coupled, seven-transmembrane receptor
family18 and are currently divided into three subtypes: a2A, a2B
and a2C (ref. 19). In the present study we found that both alveolar
macrophages and blood PMNs express all three subtypes of the a2-
adrenoceptors (Supplementary Fig. 1).
To exclude T cells or the sympathetic nerve endings as sources of
the injury-modulating catecholamines, we achieved T-cell depletion
with an antibody and sympathetic denervation by administering
reserpine. Recovery of sympathetic function after administration of
reserpine takes up to several weeks20. In the present study we har-
vested and exposed PMNs and alveolar macrophages to LPS 4 days
after administration of reserpine in vivo to determine whether the
production of catecholamines by phagocytes is impaired by reser-
pine. There was no difference in noradrenaline production between
phagocytes from control and reserpine-treated animals (Fig. 4a).
Accordingly, we induced lung injury in the presence or absence of
a2-adrenoceptor blockade in control animals and animals treated
4 days earlier with reserpine. Injury levels were significantly increased
in reserpine-treated animals, whereas a2-adrenoceptor blockade
completely abolished vascular leakage (Fig. 4c). We repeated these
experiments in vitro and in vivo 2 h after reserpine administration,
with identical results (data not shown). As expected, adrenal gland
homogenates from reserpine-treated animals had almost no detect-
able noradrenaline (Fig. 4b). In parallel experiments, mice were
depleted of CD4 T cells and the intensity of albumin leakage
was assessed. There was no change in the level of injury between
T-cell-depleted and isotype-control-treated littermates. In the
same animals, a2-adrenoceptor blockade was protective (Fig. 4d).
Bronchoalveolar lavage (BAL) fluid analysis was performed to deter-
mine whether the sympathetic nervous system and T cells were key
sources of catecholamines in current models of lung injury. Peak
levels of adrenaline occurred in BAL fluids 2 h after the initiation
of immune-complex-mediated injury (Fig. 4e). In parallel, an adre-
naline peak was found 3 h after the initiation of LPS-induced lung
injury (data not shown). Other mice were depleted of PMNs, alveolar
macrophages or T cells or were pharmacologically sympathecto-
mized and subjected to lung injury. BAL fluids were obtained and
measured 2 h after the initiation of injury. Whereas depletion of
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Figure 3 | The a2-adrenoceptor mediates the severity of experimental
acute lung injury. a–d, Acute lung injury (ALI) was induced by LPS (a, b) or
IgG IC (c, d) in rats and injury severity was assessed by vascular leak of
vascular 125I-albumin. Adrenoceptors were blocked pharmacologically as
described in the text. All data are presented as means 6 s.e.m.; n $ 5 per bar.
Asterisks in b and d indicate P , 0.01 versus LPS-induced and IC-induced
lung injury, respectively. e–k, Hematoxylin and eosin-stained lung sections.
e, Uninjured lung. f–h, LPS-injured animals. i–k, IC-injured littermates.
Sections are representative for n $ 3 per group. Neg. ctrl, negative control.
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of adrenaline in BAL fluids, reserpine-induced sympathectomy did
not decrease adrenaline levels (Fig. 4f). These data indicate that the
presence of adrenaline in BAL fluids requires PMNs and macro-
phages but not T cells. Phagocytes of adrenalectomized animals have
higher baseline levels of TH, DBH and catecholamine secretion
(M.A.F., D.R., R.P.L., A.J.C., D.E.D., B.A.N., F.S.Z., J.V.S., A. B.
Lentsch, M.S.H.-L. and P.A.W., unpublished observations). It might
be possible that the baseline production of catecholamines in pha-
gocytes is increased as a compensatory endogenous mechanism to
pharmacological sympathectomy. Last, we showed that pharmaco-
logical blockade of the catecholamine-generating TH (by using
a-methyltyrosine) and DBH (by using fusaric acid) greatly dimin-
ished the inflammatory response, whereas inhibition of the catecho-
lamine-degrading enzymes COMT (with dinitrocatechol) and MAO
(with moclobemide) significantly increased lung injury as defined by
the permeability index (Fig. 4g).
Alveolar macrophages and PMNs have a central function in
the pathophysiology of IgG IC-induced lung injury21. The a2-
adrenoreceptor is expressed on alveolar macrophages11, and modu-
lation of the a2-adrenoceptor regulates LPS-induced production of
tumour necrosis factor (TNF)-a in vitro from alveolar macro-
phages22. We sought to determine whether in vitro blockade of the
adrenoceptors, especially the a2-adrenoreceptor, might be linked to
the present findings in vivo. There was a variable inhibition in vitro
of various macrophage-derived cytokines (TNF-a, interleukin-6
and interleukin-1b) and chemokines (cytokine-induced neutrophil
chemoattractant (CINC)-1) by a1-adrenoceptor, a2-adrenoceptor,
b1-adrenoceptor or b2-adrenoceptor blockade (Supplementary
Table 1), with blockade of the a2-adrenoreceptor achieving the most
consistent suppression of mediators. Identical experiments with
PMNs revealed similar patterns (data not shown).
Taken together, the results of this study indicate that both alveolar
macrophages and blood PMNs are capable of the production of
catecholamines de novo and of their release, implicating phagocytes
as a previously unrecognized source of catecholamines. Enhanced
production or decreased generation of catecholamines (with the
use of inhibitors of catecholamine-generating or catecholamine-
degrading enzymes) increases or decreases the intensity of inflam-
matory injury, respectively. Blockade of a2-adrenoceptors in vivo
greatly decreases the intensity of inflammatory injury. In many
respects, the phagocytic system can be looked on as a diffusely
expressed adrenergic organ.
METHODS SUMMARY
Animals and anaesthesia. All studies were conducted in accordance with the
University of Michigan Committee on Use and Care of Animals. Specific patho-
gen-free male Long–Evans rats (300–325 g; Taconic) or C57BL/6 mice (Jackson
Laboratory) were anaesthetized with isoflurane (Aerrane; Henry Schein).
Isolation of PMNs and alveolar macrophages. Whole blood was drawn into
syringes containing anticoagulant citrate dextrose (ACD) (Baxter Health Care),
in a volume ratio of 1:10. Neutrophils were isolated by using Ficoll-Paque gra-
dient centrifugation (Pharmacia Biotech AB) followed by a dextran sedimenta-
tion step. After hypotonic lysis of residual red blood cells, neutrophils were
resuspended in Hanks balanced salt solution (HBSS) containing Ca21 and
Mg21. Rat alveolar macrophages were isolated by repeatedly lavaging the lungs
of anaesthetized healthy animals. After centrifugation of BAL fluids, cells were
resuspended in HBSS containing Ca21 and Mg21.
Stimulation of phagocytes by LPS. Macrophages or PMNs (3 3 106 or 5 3 106
in 1.0 ml) were isolated and incubated with 30 or 50 ng of LPS (Escherichia coli
0111:B4; Sigma Aldrich). Supernatants were obtained and frozen at 280 uC.
Enzyme-linked immunosorbent assay/enzyme immunoassay analysis of cell
supernatants. Noradrenaline and adrenaline enzyme immunoassays were

















































































































































































































































































































Figure 4 | Phagocyte-derived catecholamines mediate lung injury. a, After
sympathectomy (SNSX), noradrenaline production in supernatants of LPS-
stimulated phagocytes was assessed. Open bars, PMNs; hatched bars,
alveolar macrophages. Asterisk, P , 0.01 versus respective control (ctrl).
b, Sympathectomy was confirmed by adrenal gland homogenates. c, Severity
of IC-induced acute lung injury (IC-ALI) in sympathectomized animals.
Asterisk, P , 0.05 versus IC-ALI; two asterisks, P , 0.01 versus IC-ALI.
d, Mice were T-cell depleted, and lung injury was compared with that in
isotype-antibody-treated littermates. Asterisk, P , 0.01 versus IC-ALI.
e, Adrenaline peak was determined in BAL fluids. f, Mice were depleted
(depl.) of PMN, alveolar macrophages (AMW) or T cells or were
sympathectomized, and adrenaline was measured 2 h after IC-ALI. Asterisk,
P , 0.05 versus positive control (pos. ctrl); two asterisks, P , 0.01 versus
positive control. Neg. ctrl, negative control. g, Severity of lung injury after
inhibition of TH, DBH, COMT or MAO. Asterisk, P , 0.05 versus IC-ALI
plus vehicle; two asterisks, P , 0.01 versus IC-ALI plus vehicle. Data are
presented as means 6 s.e.m.; n $ 5 per bar.
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Alveolitis induced by IgG IC and by LPS. IgG IC-induced alveolitis was per-
formed as described previously23,24. For LPS-induced alveolitis, rats received
300mg of LPS (Sigma Aldrich) intratracheally.
Morphological assessment of lung injury. At 4 h after IgG IC deposition or 6 h
after LPS deposition, lungs were fixed by intratracheal instillation of 10 ml of
PBS-buffered (pH 7.2) formalin (10%). The lungs were further fixed in a 10%
buffered formalin solution for histological examination by tissue sectioning and
staining with haematoxylin and eosin.
Statistical analysis. All values are expressed as means 6 s.e.m. Data were ana-
lysed with ANOVA and a Student–Newman–Keuls test. Differences were con-
sidered significant at P # 0.05.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Western blot analysis of MAO-A, COMT, a2A-adrenoceptors, a2B-
adrenoceptors and a2C-adrenoceptors. After isolation and exposure to LPS,
phagocytes were lysed with Laemmli buffer containing 5% mercaptoethanol.
Samples were then separated in a denaturing polyacrylamide gel and transferred
to a nitrocellulose membrane. After blocking (5% Tris-buffered saline pH 7.0
containing 0.1% Tween 20) and washing, membranes were then incubated over-
night with primary antibodies against adrenoreceptors, MAO-A and COMT
(Santa Cruz Biotechnology) and antibodies against GAPDH (Abcam) at 4 uC.
Membranes were analysed by enhanced chemiluminescence.
Isolation of mRNA and detection of rat a2A-adrenoreceptors, a2B-
adrenoreceptors, a2C-adrenoreceptors, TH, DBH, MAO-A and COMT by
quantitative real-time PCR analysis. Total RNA was extracted from phagocytes
with Trizol reagent (Life Technologies) in accordance with the manufacturer’s
instructions. Reverse transcription was performed with 1 mg of RNA by using
AMV Reverse Transcriptase (Roche). Real-time quantitative PCR was then per-
formed with SYBR Green PCR Master Mix (Applied Biosystems). The following
primer pairs were used: rat a2A adrenoreceptor 59-CTT GGC CCT CGA CGT
GCT CTT TTG-39 (forward) and 59-CGG CGG CGC GGA ACA GG-39
(reverse); rat a2B adrenoreceptor, 59-TCG GCC ATC ACC TTT CTC ATC
CTT-39 (forward) and 59-GGG CGT CGG GGC GTT GGT C-39 (reverse); rat
a2C adrenoreceptor, 59-TGG CTC ATC TCG GCT GTC ATC TCC-39 (forward)
and 59-TGT CCC CCT CGG CAC CCT CTC-39 (reverse); rat TH, 59-AGT CTG
GCC TTC CGC GTG TTT CAA-39 (forward) and 59-GGG CGC TGG ATA CGA
GAG GCA TAG-39 (reverse); rat DBH, 59-CTG CGA CCC CAA GGA TTA TG-
39 (forward) and 59-CAG CAC GTG GCG ACA GTA GTT-39 (reverse); rat
MAO-A, 59-GTT GAG CGG CTG ATC CAC TTT GT-39 (forward) and 59-
CCG GCC TCT CCA GCT TCA CTC T-39 (reverse); rat COMT, 59-GAC
GCG AAA GGC CAA ATC AT-39 (forward) and 59-GCT GCT GCT CCC
TCT CAC ATA-39 (reverse); rat GAPDH, 59-CGG CAA GTT CAA CGG CAC
AGT CA-39 (forward) and 59-CTT TCC AGA GGG GCC ATC CAC AG-39
(reverse). Product sizes were 403 base pairs (bp) (a2A-adrenoreceptor), 427
bp (a2B-adrenoreceptor), 409 bp (a2C-adrenoreceptor), 458 bp (TH), 439 bp
(DBH), 451 bp (MAO-A), 435 bp (COMT) and 424 bp (GAPDH).
Drugs. All drugs (from Sigma Aldrich unless stated otherwise) were adminis-
tered intraperitoneally: propane-1,2-diol (vehicle; 1 ml kg21), Prazosin
(2 mg kg21), RX 821002 (10 mg kg21), metoprolol (15 mg kg21), ICI 118551
(10 mg kg21) and UK 14304 (2 mg kg21), a-methyltyrosine (200 mg kg21), fusa-
ric acid (75 mg kg21), 3,5-dinitrocatechol (50 mg kg21) and moclobemide
(20 mg kg21; Biotrend).
Depletion of CD4 T cells, neutrophils and alveolar macrophages. For deple-
tion of CD4 T cells, C57BL/6 mice were treated with 0.2 mg of CD4-specific
monoclonal antibody (GK1.5; BD Pharmingen) intraperitoneally 48 h before
induction of lung injury. Alveolar macrophages and neutrophils were depleted
as described previously25,26.
Pharmacological sympathectomy. To achieve pharmacological sympath-
ectomy, mice were injected intraperitoneally with reserpine (5 mg kg21). Four
days after reserpine injection, acute lung injury was initiated as described above.
25. Gao, H. et al. Stat3 activation in acute lung injury. J. Immunol. 172, 7703–7712
(2004).
26. Hoesel, L. M. et al. Harmful and protective roles of neutrophils in sepsis. Shock 24,
40–47 (2005).
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